Clinical Trial Update: A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

View source ↗

Summary

A completed clinical trial (e-STAR) evaluated adherence to schizophrenia treatment with long-acting risperidone microspheres.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia, Tranquilizing Agents | Status: COMPLETED